The dopamine transporter: role in neurotoxicity and human disease
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 204 (3) , 355-360
- https://doi.org/10.1016/j.taap.2004.08.013
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- α‐Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's diseaseFEBS Letters, 2004
- Sodium-Dependent Neurotransmitter TRANSPORTERS: OLIGOMERIZATION as a Determinant of Transporter Function and TraffickingMolecular Interventions, 2004
- What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?Movement Disorders, 2003
- Association of Dopamine Transporter Loss in the Orbitofrontal and Dorsolateral Prefrontal Cortices With Methamphetamine-Related Psychiatric SymptomsAmerican Journal of Psychiatry, 2003
- Modulation of dopamine transporter function by α‐synuclein is altered by impairment of cell adhesion and by induction of oxidative stressThe FASEB Journal, 2003
- Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity DisorderAmerican Journal of Psychiatry, 2002
- Cocaine abusers do not show loss of dopamine transporters with ageLife Sciences, 1997
- Low dopamine transporter mRNA levels in midbrain regions containing calbindinNeuroReport, 1994
- Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neuronsAnnals of Neurology, 1994
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983